2023-08-28 09:45:21 ET
More on Abcam ADS, Danaher, etc.
- Abcam: Further Upside Limited With Potential Acquisition In The Making, Reiterate Hold
- Third Point - Danaher: Don't Be Surprised If Growth Rate Moves To Low Teens
- Danaher: I'm Buying This Compounder On Any Weakness
- Danaher Corporation ( DHR ) Q2 2023 Earnings Call Transcript
- Danaher Corporation 2023 Q2 - Results - Earnings Call Presentation
- Danaher: A Compounding Icon At A Fair Price
- Danaher: Poised To Thrive Amidst The Bioprocessing Downturn
- Danaher: Seizing The Buying Opportunity In A Temporary Bioprocessing Slump
- Danaher agrees to buy Abcam for $24 a share in cash
- Danaher sets Sept. 30 for spinoff of Veralto
- Abcam gains on reports Danaher in lead to acquire company
- 'New world order' backfires on China and Russia amid economic disruption
- Daniel Loeb's Third Point adds Activision, Black Knight; exits Colgate Palmolive
- Starboard Value boosts stakes in Wix.com, Humana, trims Salesforce
- Danaher falls despite Q2 beat amid underwhelming guidance
- Abcam gains on report it's seeing takeover interest from Danaher, Agilent
For further details see:
Abcam deal price may have been hurt by antitrust concerns - report